TOIIW

Oncology Institute Inc

0.0383
0.0023 (6.39%)

Period:

Draw Mode:

Volume 999
Bid Price 0.0361
Ask Price 0.114
News -
Day High 0.05

Low
0.0257

52 Week Range

High
1.23

Day Low 0.036
Company Name Stock Ticker Symbol Market Type
Oncology Institute Inc TOIIW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0023 6.39% 0.0383 18:00:00
Open Price Low Price High Price Close Price Prev Close
0.0363 0.036 0.05 0.0383 0.036
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12 999 $ 0.0415333 $ 41 - 0.0257 - 1.23
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100 $ 0.0383 USD

Oncology Institute Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.37M 975.75M 975.75M $ 76.19M $ -297.15k - -125.77
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Oncology Institute News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TOIIW Message Board. Create One! See More Posts on TOIIW Message Board See More Message Board Posts

Historical TOIIW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.050.05250.0360.05163919,918-0.0117-23.4%
1 Month0.05320.08720.02570.0468734,781-0.0149-28.01%
3 Months0.1170.17720.02570.07120815,000-0.0787-67.26%
6 Months0.120.23750.02570.10834118,124-0.0817-68.08%
1 Year0.991.230.02570.347008312,691-0.9517-96.13%
3 Years1.7751.7750.02570.67121120,210-1.74-97.84%
5 Years1.7751.7750.02570.67121120,210-1.74-97.84%

Oncology Institute Description

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.